دورية أكاديمية
Outcome of BCG Vaccination in ADA-SCID Patients: A 12-Patient Series.
| العنوان: | Outcome of BCG Vaccination in ADA-SCID Patients: A 12-Patient Series. |
|---|---|
| المؤلفون: | Canarutto D; Faculty of Medicine and Surgery, Vita-Salute S. Raffaele University, 20132 Milan, Italy.; San Raffaele Telethon Institute for Gene Therapy (SR-Tiget), IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy.; Pediatric Immunohematology Unit and BMT Program, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy., Oltolini C; Clinic of Infectious Diseases, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy., Barzaghi F; San Raffaele Telethon Institute for Gene Therapy (SR-Tiget), IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy.; Pediatric Immunohematology Unit and BMT Program, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy., Calbi V; San Raffaele Telethon Institute for Gene Therapy (SR-Tiget), IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy.; Pediatric Immunohematology Unit and BMT Program, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy., Migliavacca M; San Raffaele Telethon Institute for Gene Therapy (SR-Tiget), IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy.; Pediatric Immunohematology Unit and BMT Program, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy., Tucci F; San Raffaele Telethon Institute for Gene Therapy (SR-Tiget), IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy.; Pediatric Immunohematology Unit and BMT Program, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy., Gallo V; San Raffaele Telethon Institute for Gene Therapy (SR-Tiget), IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy.; Pediatric Immunohematology Unit and BMT Program, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy., Consiglieri G; San Raffaele Telethon Institute for Gene Therapy (SR-Tiget), IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy.; Pediatric Immunohematology Unit and BMT Program, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy., Ferrua F; San Raffaele Telethon Institute for Gene Therapy (SR-Tiget), IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy.; Pediatric Immunohematology Unit and BMT Program, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy., Recupero S; San Raffaele Telethon Institute for Gene Therapy (SR-Tiget), IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy.; Pediatric Immunohematology Unit and BMT Program, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy., Cervi MC; Pediatric Infectious Diseases Division, Department of Pediatrics, Ribeirao Preto Medical School, University of Sao Paulo, Sao Paulo 05508-000, Brazil., Al-Mousa H; Department of Pediatrics, King Faisal Specialist Hospital and Research Center, Riyadh 11564, Saudi Arabia., Pituch-Noworolska A; Department of Immunology, University Children's Hospital, 30-663 Krakow, Poland., Tassan Din C; Clinic of Infectious Diseases, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy., Scarpellini P; Clinic of Infectious Diseases, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy., Silvani P; Department of Anesthesia and Critical Care, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy., Fossati C; San Raffaele Telethon Institute for Gene Therapy (SR-Tiget), IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy., Casiraghi M; San Raffaele Telethon Institute for Gene Therapy (SR-Tiget), IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy., Cirillo DM; Emerging Bacterial Pathogens Unit, Division of Immunology, Transplantation and Infectious Diseases, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy., Castagna A; Faculty of Medicine and Surgery, Vita-Salute S. Raffaele University, 20132 Milan, Italy.; Clinic of Infectious Diseases, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy., Bernardo ME; Faculty of Medicine and Surgery, Vita-Salute S. Raffaele University, 20132 Milan, Italy.; San Raffaele Telethon Institute for Gene Therapy (SR-Tiget), IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy.; Pediatric Immunohematology Unit and BMT Program, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy., Aiuti A; Faculty of Medicine and Surgery, Vita-Salute S. Raffaele University, 20132 Milan, Italy.; San Raffaele Telethon Institute for Gene Therapy (SR-Tiget), IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy.; Pediatric Immunohematology Unit and BMT Program, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy., Cicalese MP; Faculty of Medicine and Surgery, Vita-Salute S. Raffaele University, 20132 Milan, Italy.; San Raffaele Telethon Institute for Gene Therapy (SR-Tiget), IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy.; Pediatric Immunohematology Unit and BMT Program, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy. |
| المصدر: | Biomedicines [Biomedicines] 2023 Jun 24; Vol. 11 (7). Date of Electronic Publication: 2023 Jun 24. |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101691304 Publication Model: Electronic Cited Medium: Print ISSN: 2227-9059 (Print) Linking ISSN: 22279059 NLM ISO Abbreviation: Biomedicines Subsets: PubMed not MEDLINE |
| أسماء مطبوعة: | Original Publication: Basel, Switzerland : MDPI AG, [2013]- |
| مستخلص: | Vaccination with Bacillus Calmette-Guérin (BCG) can be harmful to patients with combined primary immunodeficiencies. We report the outcome of BCG vaccination in a series of twelve patients affected by adenosine deaminase deficiency (ADA-SCID). BCG vaccination resulted in a very high incidence of complications due to uncontrolled replication of the mycobacterium. All patients who developed BCG-related disease were treated successfully and remained free from recurrence of disease. We recommend the prompt initiation of enzyme replacement therapy and secondary prophylaxis to reduce the risk of BCG-related complications in ADA-SCID patients. |
| References: | Blood. 2022 Aug 18;140(7):685-705. (PMID: 35671392) J Allergy Clin Immunol. 2014 Apr;133(4):1134-41. (PMID: 24679470) N Engl J Med. 2009 Jan 29;360(5):447-58. (PMID: 19179314) Haematologica. 2021 Feb 01;106(2):641-646. (PMID: 32817285) Nat Commun. 2022 Mar 14;13(1):1315. (PMID: 35288539) Wkly Epidemiol Rec. 2018 Feb 23;93(8):73-96. (PMID: 29474026) Blood. 2016 Jul 7;128(1):45-54. (PMID: 27129325) BMJ Open. 2022 Nov 21;12(11):e063872. (PMID: 36410811) J Allergy Clin Immunol. 2021 Feb;147(2):417-426. (PMID: 33551023) J Clin Immunol. 2020 May;40(4):625-636. (PMID: 32377975) Lancet Infect Dis. 2017 Mar;17(3):285-295. (PMID: 27964822) Clin Infect Dis. 2006 Feb 15;42(4):548-58. (PMID: 16421800) BMJ Glob Health. 2022 Jan;7(1):. (PMID: 35039309) Lancet Glob Health. 2022 Feb;10(2):e207-e215. (PMID: 34895517) PLoS Med. 2011 Mar;8(3):e1001012. (PMID: 21445325) Lancet Glob Health. 2022 Sep;10(9):e1307-e1316. (PMID: 35961354) J Clin Immunol. 2022 Jan;42(1):195-198. (PMID: 34622389) Haematologica. 2015 Jul;100(7):978-88. (PMID: 26022711) N Engl J Med. 2019 Mar 14;380(11):1001-1011. (PMID: 30865794) |
| معلومات مُعتمدة: | institutional core grant Telethon Foundation |
| فهرسة مساهمة: | Keywords: enzyme replacement therapy; gene therapy; isoniazid; newborn screening; rifampin; tuberculosis |
| تواريخ الأحداث: | Date Created: 20230729 Latest Revision: 20230731 |
| رمز التحديث: | 20231215 |
| مُعرف محوري في PubMed: | PMC10376767 |
| DOI: | 10.3390/biomedicines11071809 |
| PMID: | 37509449 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder | تدمد: | 2227-9059 |
|---|---|
| DOI: | 10.3390/biomedicines11071809 |